Inclusion Criteria:

- Females with a history of T2N0M0 breast carcinoma (tumor ≤3 cm in largest dimension)

- Surgical or endoscopic segmental mastectomy or quadrantectomy (lumpectomy)

- Clean surgical margins

- No prosthesis in breast(s) to undergo treatment

- Ability to undergo lipoaspiration

- Last treatment for breast cancer ≥ 12 months prior to enrollment with absence of
recurrence (patients on anti-estrogen adjuvant therapy are NOT excluded)

- No evidence of recurrence of cancer based on mammogram or breast exam prior to
enrollment

- Objective signs of mild breast damage post Breast Conservation Therapy

- Type I Cosmetic Sequelae Classification

- A minimum of 1 cm of soft tissue (e.g. breast or fat) is available between the skin
and chest wall at the recipient site

- A minimum of two-thirds of the breast is remaining post Breast Conservation Therapy

- No continuous adhesion of skin to bone >3 cm in diameter

- The volume and shape of the defect(s) must be conducive to correction during a single
treatment session (maximum defect volume ≤150 mL in breast(s) to undergo treatment)

Exclusion Criteria:

- History of autoimmune disorder (e.g., Systemic Lupus Erythematosus [SLE])

- History of connective, metabolic or atrophic skin disease

- History of keloid scarring

- Chronic use (>7 consecutive days) of anticoagulants (such as aspirin) or NSAIDs
within 15 days prior to enrollment

- Life expectancy ≤ 2 years

- Recurrence or active malignancy requiring radiation or surgical treatment ≤12 months
prior to enrollment

- Presence of any other known malignancy

- Body Mass Index (BMI) >30

- Plan to undergo weight reduction surgery or foresee any significant weight changes
during the study (defined as changes in BMI >5 compared to baseline

- Presence of contraindications to MRI